Masonic Cancer Center, University of Minnesota

The Masonic Cancer Center, University of Minnesota (MCC), exists to reduce the burden of cancer on Minnesotans and beyond. We work to create a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; we apply that knowledge to improve quality of life for patients and survivors; and we share our discoveries with other scientists, students, professionals, and our community. Find out more at cancer.umn.edu

 

Masonic Cancer Center, University of Minnesota
A

Clonal Hematopoiesis

By Masonic Cancer Center, University of Minnesota FEATURING Amy DeZern
By Masonic Cancer Center, University of Minnesota FEATURING Amy DeZern
24 views
June 6, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy
Videos
30:40

New

Chemotherapy-Induced Hair Loss: Insights and Effective Strategies

Masonic Cancer Center, University of Minnesota

M. Hordinsky

130 views
37:17

New

Transforming Cancer Care Through Data

Masonic Cancer Center, University of Minnesota

S. Volchenboum

27:04

New

Proteomic Approaches to Nominate Drug Targets and Assess Biomarkers …

Masonic Cancer Center, University of Minnesota

J. Drake

23 views
19:22

New

Targeting RET Kinase in Neuroendocrine Prostate Cancer

Masonic Cancer Center, University of Minnesota

J. Drake

49:40

The Genetic Epidemiology and Early-Life Origins of Childhood Leukemia

Masonic Cancer Center, University of Minnesota

A. de Smith

10 views
26:16

Blood Cancers Basics

Masonic Cancer Center, University of Minnesota

Z. Sachs

22 views
41:10

Canine Cancer Immunotherapy: Linking Mouse and Human Using Dog Natur…

Masonic Cancer Center, University of Minnesota

R. Canter

14 views
55:45

Sleepwalking Through Evolution: A Tale of Dormancy and Hormone Depen…

Masonic Cancer Center, University of Minnesota

L. Magnani

115 views
07:26

ASCO® 2024 Insights: "TRANSFORMER Trial - Blood-Based Markers of Dif…

2024 ASCO® Annual Meeting Insights Hub

E. Antonarakis

167 views
24:39

Masonic Cancer Center Cardio-Oncology Updates

Masonic Cancer Center, University of Minnesota

S. Konety

25 views
51:29

The Role of Autologous Transplant and Cellular Therapy for Solid Tum…

Masonic Cancer Center, University of Minnesota

N. Zorko

77 views
42:36

Current Status of Head and Neck Cancers

Masonic Cancer Center, University of Minnesota

F. Ondrey

124 views
23:53

Overview of Ovarian Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

276 views
17:48

Overview of Uterine/Endometrial Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

230 views
06:41

Overview of Cervical Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

189 views
03:20

Overview of Vulvar/Vaginal Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

103 views
15:50

Disparities in Gynecologic Cancers

Masonic Cancer Center, University of Minnesota

J. Mattson

65 views
54:16

Understanding Variations in Risk of Lung Cancer Among Smokers

Masonic Cancer Center, University of Minnesota

J. Yuan

128 views
51:05

Therapy-Induced Immunosenescence: Mechanisms, Implications, and Pote…

Masonic Cancer Center, University of Minnesota

B. Zordoky

25 views
30:32

Pathways to Prevention: Strategies to Address Cancer Disparities in …

Masonic Cancer Center, University of Minnesota

S. Xiong

25 views
05:51

Lung Cancer Prevention: Tobacco Cessation & Prevention

Masonic Cancer Center, University of Minnesota

A. Wilhelm

225 views
44:29

Preventing and Remediating Accelerated Aging in Survivors of Childho…

Masonic Cancer Center, University of Minnesota

K. Ness

44 views
49:25

From Rare to Well-Done: The Epidemiology of Ewing Sarcoma

Masonic Cancer Center, University of Minnesota

L. Spector

80 views
54:21

Innate Lymphoid Cells and Cancer: What’s the Connection?

Masonic Cancer Center, University of Minnesota

M. Caligiuri

29 views
49:46

Biomarkers and Biology: Treatment Resistance in Advanced Prostate Ca…

Masonic Cancer Center, University of Minnesota

J. Lang

272 views
44:34

ALL: The Changing Shape of MRD

Masonic Cancer Center, University of Minnesota

S. Tracy

97 views
36:24

CMV and Patient-Reported Outcomes in Ovarian Cancer

Masonic Cancer Center, University of Minnesota

R. Vogel

75 views
53:58

Drug Targets and Synthetic Vulnerabilities in Sarcoma: Our Experienc…

Masonic Cancer Center, University of Minnesota

D. Largaespada

84 views
30:40

Latest in Pancreatic Cancer Research: The Development of Oncolytic A…

Masonic Cancer Center, University of Minnesota

M. Yamamoto

79 views
47:46

CellTAC: Tumor Eradication With T-Cell Targeting Chemically Self-Ass…

Masonic Cancer Center, University of Minnesota

C. Wagner

27 views
42:09

Hormone Deficiencies After Cancer: Diagnosis, Risks, & Benefits of T…

Masonic Cancer Center, University of Minnesota

B. Miller

214 views
49:31

The Time Toxicity of Cancer Care

Masonic Cancer Center, University of Minnesota

A. Gupta

84 views
53:10

Can We Eliminate Cervical Cancer?

Masonic Cancer Center, University of Minnesota

S. Kulasingam

128 views
19:31

Masonic Cancer Center Updates on the Colorectal Cancer Research

Masonic Cancer Center, University of Minnesota

S. Subramanian

58 views
08:32

ASCO GU 2023 Real-World Assessment of AR-LBD Mutations in mCRPC

ASCO GU 2023 Conference Coverage

E. Antonarakis

64 views
47:59

Improving Care Delivery and Outcomes for Older Patients With Cancer …

Masonic Cancer Center, University of Minnesota

S. Mohile

46 views
49:21

The Microtubule Severing Protein UNC-45A in Cancer and Neurodegenera…

Masonic Cancer Center, University of Minnesota

M. Bazzaro

15:25

Unraveling the Proteome of Extracellular Vesicles in Prostate Cancer

Masonic Cancer Center, University of Minnesota

M. Ludwig

17 views
12:04

The Role of Mineralocorticoid Receptor Signaling in TNBC

Masonic Cancer Center, University of Minnesota

J. Austin

46 views
47:50

Mechanisms of Progression and Aggressive Biology of TP53-Mutated AML

Masonic Cancer Center, University of Minnesota

Z. Sachs

64 views
11:12

ASH 2022 Gene Edited Off-the-Shelf NK Cells for Treating Hematologic…

ASH 2022 Conference Coverage

J. Miller

80 views
52:14

The Obesity Paradox in Cancer Immunotherapy: Linking Preclinical and…

Masonic Cancer Center, University of Minnesota

W. Murphy

15 views
44:59

Germline TP53 Variants & Cancer: Lessons Learned From Li-Fraumeni Sy…

Masonic Cancer Center, University of Minnesota

S. Savage

25 views
54:21

Leveraging Tri-Specific Killer Engagers to Enhance NK Cell Function …

Masonic Cancer Center, University of Minnesota

M. Felices

51:15

Cooked Meat and Prostate Cancer

Masonic Cancer Center, University of Minnesota

R. Turesky

2.3K views
26:55

Breast Cancer Imaging Updates

Masonic Cancer Center, University of Minnesota

M. Ekwochi

394 views
54:05

The Innate and Adaptive Responses of NK Cells

Masonic Cancer Center, University of Minnesota

J. Sun

7 views
50:55

Role of the Growth Hormone/IGF-1 Axis in Breast and Prostate Cancers

Masonic Cancer Center, University of Minnesota

P. Marker

37 views
44:24

Molecular Biology, Epidemiology, and Causes of Bone Cancer

Masonic Cancer Center, University of Minnesota

L. Spector

29 views
42:31

Understanding Intravascular Delivery of Adenovirus Gene Therapy Vect…

Masonic Cancer Center, University of Minnesota

A. Byrnes

35:41

Optimal Dose Determination in Phase 1 Clinical Trials

Masonic Cancer Center, University of Minnesota

P. LoRusso

10 views
44:50

New Therapeutic Discoveries and Mechanisms for CRPC

Masonic Cancer Center, University of Minnesota

K. Kelly

91 views
55:05

Clonal Hematopoiesis

Masonic Cancer Center, University of Minnesota

A. DeZern

24 views
25:40

State of the Masonic Cancer Center - 2022 MCC Annual Research Sympos…

Masonic Cancer Center, University of Minnesota

D. Yee

12 views
16:38

Molecular Regulation of Lung Cancer Growth: DARPP-32 Overview, D2R A…

Masonic Cancer Center, University of Minnesota

L. Hoeppner

13 views
11:34

DARPP-32, t-DARPP and SCLC Growth: ASCL1-Regulated DARPP-32 and t-DA…

Masonic Cancer Center, University of Minnesota

L. Hoeppner

16 views
19:41

EGFRm NSCLC: Resistance Mechanisms, Role of DARPP-32 in Tumor Growth

Masonic Cancer Center, University of Minnesota

L. Hoeppner

48 views
29:24

Precision Genome Engineering in T Cells for Cancer Immunotherapy: AC…

Masonic Cancer Center, University of Minnesota

B. Webber

22:26

Clinical Application of Genome Editing: TIL Therapy, CISH, CRISPR/Ca…

Masonic Cancer Center, University of Minnesota

B. Webber

6 views
53:15

Gut Microbiota and Infectious Complications of Chemotherapy: Dysbios…

Masonic Cancer Center, University of Minnesota

A. Rashidi

48 views
31:15

Targeting FAS to Enhance T Cell Activity in cGVHD: How Is Treg Suppr…

Masonic Cancer Center, University of Minnesota

E. Aguilar

20:38

AR Alternative Polyadenylation as a Therapeutic Vulnerability in Pro…

Masonic Cancer Center, University of Minnesota

K. Tietz

10 views
56:19

A Systems Perspective on Endocrine Resistance in Breast Cancer

Masonic Cancer Center, University of Minnesota

R. Clarke

38 views
46:12

Targeting CD83 to Reduce AML Relapse and GVHD After alloHCT

Masonic Cancer Center, University of Minnesota

B. Betts

15 views
53:47

Understanding and Addressing Liver Cancer Disparities in Asian Ameri…

Masonic Cancer Center, University of Minnesota

J. Ha Thi Dang

11 views
45:25

Lineage Plasticity and the Neuroendocrine Phenotype in Prostate Canc…

Masonic Cancer Center, University of Minnesota

H. Beltran

13 views
43:31

From Bench Science to the Community: An Example of Using the Masonic…

Masonic Cancer Center, University of Minnesota

D. Mowls Carroll, S. Murphy

12 views
47:20

Two-Hit Models to Understand the Mechanisms of Latent Doxorubicin Ca…

Masonic Cancer Center, University of Minnesota

B. Zordoky

53:25

NanoString GeoMx Digital Spatial Profiling of Triple Negative Breast…

Masonic Cancer Center, University of Minnesota

K. Beckman, M. Sanders, A. Nelson, F. Rodriguez, G. Barthel, C. Urben

18 views
42:41

Cancer Communication Intervention and Dissemination Development for …

Masonic Cancer Center, University of Minnesota

E. Cohen

9 views
35:55

Bridging Pre-Clinical Drug Screening With Patient Molecular Profiles…

Masonic Cancer Center, University of Minnesota

R. Stephanie Huang

33:10

Survival of African-American and Caucasian Men With mCRPC After Sipu…

Masonic Cancer Center, University of Minnesota

O. Sartor

15 views
18:34

2020 Update on nmCRPC: Are Apalutamide, Darolutamide & Enzalutamide …

Global Congress on Prostate Cancer - PROSCA 2020

C. Ryan

459 views